NUTRA PHARMA CORP. (NPHC)

Every figure this model derived for NPHC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 26,052 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 29,781 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 463,119 AssetsCurrent 2026-06-30
current liabilities 21,696,808 LiabilitiesCurrent 2026-06-30
equity -21,208,753 StockholdersEquity 2026-06-30
interest expense 23,985 InterestExpense 2026-06-30
ocf -1,049,602 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 160,815 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 39,833 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NPHC on one particular measure came for.

RatioValue
cash operating margin-986.64
current ratio0.02
current ratio reported0.02
deferred revenue growth-27.04
dilution pct1.37
fcf margin-668.88
growth cv0.7
interest cover-68.24
operating margin-1017.76
owner earnings margin-693.65
revenue growth-49.01
revenue growth per share-49.7
roic-34.26
rule of 40-1066.76
sbc pct revenue24.77

What to be careful about

What this model itself distrusts about NPHC's figures. Written by the derivation as it ran, not added afterwards.